表紙
市場調査レポート

糸球体腎炎:世界の治験動向

Glomerulonephritis Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 325940
出版日 ページ情報 英文 78 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
糸球体腎炎:世界の治験動向 Glomerulonephritis Global Clinical Trials Review, H2, 2015
出版日: 2015年09月10日 ページ情報: 英文 78 Pages
概要

当レポートでは、糸球体腎炎に関する臨床研究の最新動向について調査し、地域・進捗状況・フェーズ (相) ・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、世界各国の主要企業・機関での進行状況、有望な薬剤の比較といった情報を盛り込んでお届けします。

イントロダクション

  • 糸球体腎炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:泌尿生殖器系・性ホルモン治療薬の治験における糸球体腎炎の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:泌尿生殖器系・性ホルモン治療薬の治験における糸球体腎炎の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

糸球体腎炎治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Isis Pharmaceuticals, Inc.
    • GlaxoSmithKline plc
    • Celldex Therapeutics, Inc.
    • Anthera Pharmaceuticals, Inc.
    • Pharmalink AB
    • Osprey Pharmaceuticals U.S.A., Inc.
    • La Jolla Pharmaceutical Company
    • 第一三共
    • Bristol-Myers Squibb Company
    • Amgen Inc.
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • Chinese University of Hong Kong
    • Radboud University
    • National Taiwan University Hospital
    • Centre Hospitalier Universitaire de Saint Etienne
    • Columbia University
    • Hospital Authority
    • The Rogosin Institute
    • Mayo Clinic
    • Ministry of Health, Labour and Welfare, Japan

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2856CTIDB

GlobalData's clinical trial report, "Glomerulonephritis Global Clinical Trials Review, H2, 2015" provides an overview of Glomerulonephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Glomerulonephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Glomerulonephritis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Glomerulonephritis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Glomerulonephritis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Regulus Therapeutics Inc.
      • Clinical Trial Overview of Regulus Therapeutics Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Celldex Therapeutics, Inc.
      • Clinical Trial Overview of Celldex Therapeutics, Inc.
      • Anthera Pharmaceuticals, Inc.
      • Clinical Trial Overview of Anthera Pharmaceuticals, Inc.
      • Alexion Pharmaceuticals, Inc.
      • Clinical Trial Overview of Alexion Pharmaceuticals, Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Alfa Wassermann S.p.A
      • Clinical Trial Overview of Alfa Wassermann S.p.A
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • Columbia University
      • Clinical Trial Overview of Columbia University
      • Hospital Authority
      • Clinical Trial Overview of Hospital Authority
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Ministry of Health, Labour and Welfare, Japan
      • Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan
      • National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • Radboud University
      • Clinical Trial Overview of Radboud University
      • University of Washington
      • Clinical Trial Overview of University of Washington
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Glomerulonephritis Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Glomerulonephritis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Glomerulonephritis Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Glomerulonephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Regulus Therapeutics Inc., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals, Inc., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexion Pharmaceuticals, Inc., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfa Wassermann S.p.A, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015*

List of Figures

  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Glomerulonephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Glomerulonephritis to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Glomerulonephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Glomerulonephritis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Glomerulonephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Glomerulonephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top